-
公开(公告)号:US20220273713A1
公开(公告)日:2022-09-01
申请号:US17622563
申请日:2020-06-26
申请人: The University of Melbourne , Olivia Newton-John Cancer Research Institute , CSL INNOVATION PTY LTD
发明人: Andreas BEHREN , Jonathan CEBON , Marc Rigau CORTAL , Thomas Samuel FULFORD , Dale Ian GODFREY , Andrew HAMMET , Simone OSTROUSKA , Con PANOUSIS , Adam Peter ULDRICH
摘要: The present disclosure relates to methods for inhibiting activation of γδ T cells that express a Vγ9+ TCR in a subject by administering a BTN2A1 antagonist to a subject as well as methods for inducing or enhancing γδ T cells that express a Vγ9+ TCR in a subject by administering a BTN2A1 antagonist to a subject. The disclosure additionally relates to BTN2A1 antagonists and BTN2A1 agonists.